Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Status unconfirmed · Phase 2

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with recurrent or refractory head and neck cancer.

Key facts

Study ID

NCT00003327

Run by

Theradex

People needed

60

Starts

1997-09-01

Last updated by the study team

2008-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• California Cancer Center — Fresno, California, United States
• Loma Linda University Medical Center — Loma Linda, California, United States
• Memorial Regional Cancer Center at Memorial Regional Hospital — Hollywood, Florida, United States
• Sylvester Cancer Center, University of Miami — Miami, Florida, United States
• Savannah Hematology Oncology Associates — Savannah, Georgia, United States
• Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
• Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana, United States
• Maine Center for Cancer Medicine and Blood Disorders — Scarborough, Maine, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Kansas City Internal Medicine — Kansas City, Missouri, United States
• Lourdes Regional Cancer Center — Binghamton, New York, United States
• Saint Vincent Catholic Medical Center of New York — New York, New York, United States
• Presbyterian Healthcare — Charlotte, North Carolina, United States
• Akron City Hospital — Akron, Ohio, United States
• Medical Oncology Hematology Associates, Inc. — Dayton, Ohio, United States
• Reading Hospital and Medical Center — Reading, Pennsylvania, United States
• Joe Arrington Cancer Research and Treatment Center — Lubbock, Texas, United States
• Cancer Care Institute of South Texas — San Antonio, Texas, United States
• Danville Hematology and Oncology, Inc. — Danville, Virginia, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.